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parietal tumor localization was a predictor for a higher 
contralateral hippocampal dose (p=0.01). 
 
Conclusion: A substantial reduction of the dose to the 
contralateral hippocampus is technically feasible when VMAT 
is used instead of our standard 3D-CRT planning strategy. The 
amount of sparing that can be achieved strongly depends on 
the individual patient geometry. Whether this approach is 
able to conserve the neurocognitive status without 
compromising the oncological outcome for patients with 
glioblastoma needs to be investigated in the setting of 
prospective clinical trials. 
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Purpose or Objective: Bone metastases are a frequent and 
disturbing complication of cancer. The challenge of 
optimizing dose coverage of the concave shape of the sacrum 
along with its close proximity to the rectum, intestines and 
femoral heads lead us to investigate whether the VMAT 
technique is advantageous when compared to 3D treatment. 
 
Material and Methods: Twenty three consecutively treated 
patients with sacral metastases in 2013-2014 were included 
in a comparative treatment-planning study evaluating VMAT 
and 3-D planning. The statistical analysis included the T- 
test, assuming Unequal Variance (one tail). Calculation of the 
p-value for the comparative results applied. Our null 
hypothesis was that VMAT is better than 3D technique, and 
our alternative hypothesis was that 3D technique is superior 
to VMAT. 
 
Results: The PTV coverage was identical in VMAT and 3D 
planning. Median values and V15 for the intestinal exposure 
showed no statistically significant difference between the 3D 
planning and VMAT: 9.28 Gy (SD 2.25) and 47.0 ml (SD 68.62) 
versus 8.97 Gy (SD 2.18) and 18.45 ml (SD 69.56), 
respectively. However, on an individual per case assessment 
it appears that the lower exposure of the bowel depends on 
the small bowel/ sacrum volumes ratio. The benefit for VMAT 
emerges if such a ratio exceeds one. The median values for 
the rectum 3D and VMAT were 11.34 Gy (SD 5.14) and 7.7 Gy 
(SD 2.76), respectively. The median 3D and VMAT exposure of 
the femoral head were 1.78 (SD 2.94) Vs 4.006 (SD 2.1) on 
the left and 1.74 (0.9) Vs 4.26 (SD 1.8) on the right side for 
the 3D and VMAT, respectively. 
 
Conclusion: Good sacral coverage is achievable with either 3-
D or VMAT approaches. VMAT is advantageous vis-à-vis the 
rectal exposure and when relatively large amounts of small 
bowel course through an individual patient's fields. The 3-D 
approach, however, retains benefit for femoral protection, a 
finding that may have implications for patients with arthritis 
and osteopenia. 
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Purpose or Objective: In Conventional Radiotherapy (CRT), 
Total Body Irradiation (TBI) is generally performed at long 
Source Skin Distance using diodes to drive the delivered dose. 
The dose distribution is usually not well assessed (measured 
only in a few points) and was shown to be strongly 
heterogeneous. This technique also leads to acute and late 
toxicity. Helical Tomotherapy (Accuray Inc., Sunnyvale, CA) 
for TBI is implemented in some centers. Compared to CRT, 
Tomotherapy allows the delivery of the prescribed dose with 
a high level of accuracy and homogeneity. Organs-at-risk can 
be spared and the dose distribution is known before the 
treatment. Two technical issues have to be solved. First, the 
patient must be treated using two plans, head first (HF) and 
feet first (FF) due to limited supero-inferior (SI) table 
motion. At the junction of these two plans, the dose must be 
delivered with particular care. Moreover, the planning target 
volume (PTV) is the entire body, including the skin. A safety 
margin in the air surrounding the body should be added to 
take into account setup errors. Using inverse planning, 
however, can result in over-fluence peaks in the skin region. 
The aim of this work is to present our solution for these two 
issues, our optimized planning protocol and our clinical 
results after one year of practice (outcome for 15 patients). 
 
Material and Methods: Patient treatment position is shown 
hereafter. Thermoplastic masks are placed on the head and 
the thorax (not the legs). Two CTs are acquired (HF and FF). 
At the planning station, the whole body (cropped 3 mm under 
the skin) is divided into 10 PTVs. At the junction (~halfway up 
the thighs), 4 PTVs (thickness 2 cm) are drawn to deliver the 
dose with the degraded penumbra methodology: decreased 
dose is delivered during HF plan and increased dose during FF 
plan. Different sets of doses were tested. The resulting dose 
distribution in the presence of simulated set-up errors (SSUE) 
is computed to find the combination that insures optimal 
dose coverage of the junction. Moreover, to insure dose 
coverage of legs in presence of SSUE, several Virtual Boluses 
(VB) were tested. A VB is a bolus added at planning, but not 
present during treatment. Several thicknesses and densities 
were tested on a phantom study: in presence of SSUE, the 
dose coverage and dose increase (due to the methodology) 
were assessed. 
 
 
 
Results: The best combination of PTV doses at the junction is 
presented in table: V95% stays higher than 96% even in the 
case of a SSUE of 1 cm (SI). The optimal VB is an 8 mm thick 
VB (density=0.4). This allows a good coverage (V95%>95%) for 
a large lateral SSUE (up to 2.9 cm). Underestimation of dose 
using this VB (planning vs measure) is 1.5%. 
 
 
Conclusion: This study presents our optimized planning 
parameters. Since November 2014, 15 patients were treated 
with a dose of 2 or 12 Gy. Dose to lungs was limited to 9 Gy. 
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Most of the patients have been treated for acute leukemia 
with allogeneic transplant. 
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Purpose or Objective: Breast cancer patients are among the 
long-term survivors of radiotherapy and therefore the long-
term cardiopulmonary toxicity due to the treatment should 
be reduced to a minimum. However, complication rates could 
be further increased when intramammary nodes are included 
in the target due to their proximity to the heart and the 
lungs. Several techniques could be used to decrease the dose 
to the normal tissues and consequently the rates of late 
complications, including proton beam radiotherapy and 
respiratory gating. This study aims to investigate the 
potential for normal tissue sparing for the treatment of 
intramammary nodes in breast cancer radiotherapy using 
scanned proton beams with or without respiratory gating. 
 
Material and Methods: The study was performed on CT-
datasets acquired from ten left-sided patients during 
enhanced inspiration gating (EIG) and free-breathing (FB). 
The patients were planned with intensity modulated proton 
therapy (IMPT) for locoregional breast treatment. The 
prescribed dose to the target was 50 GyRBE in 25 fractions, 
assuming an RBE of 1.1. Different plans were performed for 
breast and supraclavicular nodes respectively breast, 
supraclavicular and intramammary nodes (IMN). The 
implications of including IMN in the target volume were 
evaluated from the point of view of the doses to the organs 
at risk for cardiopulmonary complications. 
 
Results: Inclusion of the IMN in the target volume led to a 
small increase of the cardiopulmonary burden. Thus, in FB 
cases the average dose to the heart increased from 0.3 to 0.4 
GyRBE and the average dose to the lung increased from 6.1 
to 6.6 GyRBE, while the average dose to the left anterior 
descending artery (LAD) decreased from 4.1 to 3.8 GyRBE. 
For EIG cases the average dose to the heart was almost 
unchanged (0.2 GyRBE), the average dose to the lung 
increased from 6.9 to 7.4 GyRBE and the average dose to the 
LAD decreased from 3.3 to 2.6 GyRBE. Other dosimetric 
parameters of interest showed a similar trend when IMN were 
included in the target. These parameters are much lower 
than those that could be achieved in conventional 
radiotherapy with photons, especially with respect to the 
cardiovascular burden, irrespective of whether respiratory 
gating is used or not. 
 
Conclusion: The results of this study indicate that 
radiotherapy with scanned proton beams has the potential of 
significantly limit the cardiopulmonary burden compared to 
photon RT when including the IMN in breast cancer 
radiotherapy. 
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Purpose or Objective: Stereotactic ablative radiotherapy 
(SABR) for the lung primary and metastatic tumors aims to 
increase the local control, survival and quality of life. Deep 
inspiration breath hold (DIBH) using 4D CT for simulation 
minimizes respiratory motion and reduces the toxicity risk by 
decreasing margins. In this study, we aimed to compare the 
dosimetric results of different devices and techniques of 
SABR using volumetric arc therapy (VMAT) with DIBH in the 
lung tumors. 
 
Material and Methods: CT datasets of 7 patients with right-
sided lung cancer performed with RPM system (Varian, Palo 
Alto) was used. Median PTV was 13.2cc. Dose prescription 
objective was to cover 98% of the target volume by D98% 
which was 50 Gy/5 fractions. Four different VMAT plans were 
made on Eclipse TPS (Varian, Palo Alto) using AAA algorithm. 
Plan A consisted of TrueBeam,120HDMLC, 6MV-FFF, without 
jaw tracking, Plan B TrueBeam,120HDMLC, 6MV-FFF, with jaw 
tracking, Plan C TrueBeam,120HDMLC, 6MV, without jaw 
tracking, Plan D with Trilogy, 120MilleniumMLC, 6MV, without 
jaw tracking. Three partial arcs using 210 degrees were used 
to generate the plans under the same optimization 
conditions. Monitor Unit (MU), beam-on time (BOT), Gradient 
Index (GI), lung V20 and V5, dose at 2 cm from PTV (D2cm), 
PTV(Dmax) and PTV(Dmin) were assessed for comparison. 
Wilcoxon test was used for statistical evaluation. 
 
Results: No statistically significant differences were found 
for total MU, D2cm and PTV(Dmin) between the four plans. 
Mean PTV(Dmax) values were lower in Plan C with HDMLC 
compared to Plan D with MilleniumMLC (122.9%±3.9 vs 
126.8%±3.7, p=.018). At GI assessment; there was no 
significant difference between plans with and without jaw-
tracking. However, there was a significant difference 
between Plan C and Plan D (4.4±0.5 vs 4.8±0.6, p=.018); and 
between Plan A (FFF) and Plan C (FF) (4.2±0.4 vs 4.4±0.5, 
p=.018). V20 and V5 was lower in Plan C compared to Plan D 
(2.8%±1.5 vs 3.3%±1.5, p=.028 and 15.1%±5.3 vs 16.0%±5.6, 
p=.018).; V5 was lower in Plan A compared to Plan C 
(14.4%±5.1% vs 15.1%±5.3). BOT was significantly shorter 
between Plan A and Plan C (167.5 sec±20.4 vs 390.5 
sec±47.8, p=.018). 
 
Conclusion: In SABR with WMAT using DIBH, we observed 
some improvements by using HDMLC compared to 
MilleniumMLC and FFF compared to FF beams. However, we 
could not observe additional benefit with jaw tracking in the 
FFF mode. Major advantage of FFF was the shorter BOT, 
which may finally improve the patient compliance in SABR 
using DIBH technique. 
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Purpose or Objective: In locally advanced NSCLC Concurrent 
chemo/Radiation is the key most important treatment 
approach. However delivering adequate radiation dose to 
improve treatment results is limited by the tolerance of 
nearby structures (lungs, esophagus, heart etc…), and by the 
intrafractional uncertainties resulting from prolonged 
treatment time of the conventional techniques. We have 
compared VMATplanes Vs. 3D CRT in inoperable advanced 
lung cancer cases. 
 
Material and Methods: Ten cases of previously treated lung 
cancer with 3DCRT planes ( minimum of 4 beams) were 
replanned with VMAT optimization using 2 half arcs. Both 
planes were performed on Eclipse© planning system (version 
11) with AAA-algorithm and linear accelerator UNIQUE © of 
energy 6Mv , dose rate of 600 cGy/min , and 120 multileaf 
collimator. The dose was prescribed as 60Gy / 30fr to the 
CTV surrounded with margin of 1.5cm for the PTV. Plans 
were compared for coverage , avoidance of organs at risk , 
and total number of MU. 
 
